ACT-TIL and ANV419 for Advanced Melanoma.
Clinical trial NCT05869539 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05869539
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2026-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.